Roivant Social Ventures

When Ethan Hsu was in high school his father developed diabetic retinopathy, a chronic eye condition that occurs when diabetes damages the retina's blood vessels. Through a clinical trial, Ethan's dad was able to receive treatments that drastically improved his vision. Ethan saw first-hand the dramatic impact that drug development can have on quality of life for sick patients, which inspired him to begin pursuing a career in medicine through pharmacology competitions while he was still in high school. Ethan was the first person in his family to graduate from college and received a Bachelor of Science in Cellular and Molecular Biology from the The University of Texas at Austin. As an undergraduate he conducted research in the Welsh Lab at MD Anderson Cancer Center. To date, he has published eight papers focused on treatment advancements in Immunology and Oncology. This summer Ethan is serving as a Research and Development (R&D) Intern for Roivant Sciences' Chemistry, Manufacturing, and Control (CMC) team. This internship is offering him the opportunity to further his research experience while directly learning about drug development. "I've always wanted to have hands-on experience in the pharmaceutical industry and I think that the work of the R&D department in Roivant's CMC is captivating, because the nature of the work is so new. The work is constantly growing and changing. For instance, even within the first week of my internship I was already getting to dive in on researching new technologies that not many people have gotten to touch. It's a great place to grow." Read more about Ethan's internship and Roivant Social Ventures' 2024 Access to Medicines Internship Program here: https://lnkd.in/gCRBGeDn UNC Eshelman School of Pharmacy #researchanddevelopment #research #healthcare #access #impact #medical #pharma #therapeutics #therapeutic #innovation #medicine #medicines #clinicaltrials #clinicaltrial #accessibility #healthcarenews #healthcareinnovation #raredisease #immunology #oncology #diabeticretinopathy #retinopathy

Congratulations to Caroline Eason, Roivant Social Ventures 2023 Global Access Fellow, on being selected as an inaugural ACT Community Pharmacy Student Scholar Leader through the American Association of Colleges of Pharmacy (AACP)! She was chosen for this role based on her passion and dedication to transforming community pharmacy practice. During her 2023 Global Access Fellowship Caroline volunteered with Med Aditus, a 501(c)(3) nonprofit corporation with a mission to improve access to affordable quality medicines for patients in sub-Saharan Africa. Read more about Caroline's fellowship experience here: https://lnkd.in/gK2qN5cU

Increasing Global Access to Medicines Roivant Sciences and Roivant Social Ventures (RSV) have partnered to host the Access to Medicines Internship and Fellowship Program, providing real-world drug development experience to talented PharmD students. This summer Magdalene Mallory is serving as an RSV Global Access Fellow, where she is using her grant award to volunteer at Goodlife Access and Goodlife Pharmacy Africa in Rwanda, and is leading initiatives to: - Conduct community healthcare clinic days that are creating access to otherwise unavailable blood pressure and blood glucose screenings for hundreds of community members in Kigali. - Create patient materials for post-screening healthcare education that provide next steps for building better health.  - Standardize screening techniques for providers to promote sterile practice, patient privacy, and continuity of care. - Assist in the opening of new pharmacies. - Create and present a proposal on the creation of non-communicable disease screening/consultation rooms, including, but not limited to scheduling, building, budget, staffing requirements, and educational marketing to community members. - Contribute to the designing and setting up of patient consultation rooms in new pharmacies. We sat down with Magdalene to learn more about what drives her work and how her fellowship in Rwanda will impact her career development. Magdalene grew up in a small town in Texas where she noticed early on that accessing healthcare created a difficult challenge within her community. From an early age she began volunteering at Center of Hope alongside her parents, where she witnessed firsthand the barriers individuals face accessing basic supplies and healthcare services. Magdalene shared, "From the very beginning I have made it my personal mission to help increase access and trust for underserved patients." This passion to build patient-centered access is deeply rooted in personal experience for Magdalene. Growing up she remembers watching her mother travel three to four hours to see physicians that she felt she could trust to provide proper care for herself and her family. Magdalene became hyper aware of and educated on the mistrust of our medical system that marginalized communities have developed over time. Magdalene's Global Access Fellowship has created the opportunity for her to put the critical skillsets she has developed through her PharmD program directly into action. "The work we are doing through RSV and Goodlife in Kigali (Rwanda) is merging my passion for treating underserved patients with my interests in both clinical and industry work. I'm so excited to already be witnessing just how impactful my work can be to the communities that I am dedicated to serving!" Read Madgalene's full spotlight here: https://lnkd.in/gBsjjp7b #drugdevelopment #biopharma #globalimpact UNC Eshelman School of Pharmacy Goodlife Rwanda

2024 Access to Medicines Summer Internship Program Roivant Sciences, Roivant Social Ventures (RSV), and Elutia have partnered to provide hands-on internship opportunities in drug development for talented PharmD students. The intentions of this program are to expand access to medicines to underserved populations, and to further UNC Eshelman School of Pharmacy's goal of providing future industry leaders with pharmaceutical experience during their PharmD tenure. Reflecting on her experience as Roivant's 2023 Diversity in Pharma Research and Development Intern, Hannah Summers shared, “This experience has been nothing short of transformative. I have had the chance to delve into the various components of a pharmaceutical quality system, such as the importance of regulatory history and inspections, supplier qualification, and review of controlled documents, while witnessing the development of life-changing drugs, and actively participating in various aspects of the drug development process. These hands-on experiences have fostered a deeper understanding and appreciation for the work and dedication it takes to develop innovative medications.” We congratulate the following talented students on their 2024 internships: - Derek Bassett, Corporate Strategy Intern with Elutia, a biotech company led by RSV Advisory Board member C. Randal Mills, Ph.D. Elutia focuses on a proprietary drug-eluting biomaterial platform that stands at the forefront of medical innovation. - Amanda Bowlin, Regulatory Strategy Intern with Roivant Sciences. - Mackenzie Greene, RSV Global Access Fellow, volunteering with Goodlife Access and Goodlife Pharmacy Africa in Rwanda, Africa.  - Ethan Hsu, Chemistry, Manufacturing, and Control (CMC) Intern with Roivant Sciences' Research and Development (R&D) team. - Magdalene Mallory, RSV Global Access Fellow, volunteering with Goodlife Access and Goodlife Pharmacy Africa in Rwanda, Africa. During the Spring 2024 semester all interns completed RSV's "Making Medicines" course. To read more about this year's class, click here: https://lnkd.in/gBFeY99a #healthcare #equity #internship #internships #impact #medical #pharma #therapeutics #therapeutic #medicine #medicines #socialimpact #medical #medicaldevices #tech #technology #techforgood #globalimpact #globalcommunity #globalization #access #accessibility #healthcarenews #healthcareinnovation #drugdiscovery #drugdevelopment #biopharma #pharmaceuticalindustry

I am excited to announce that I have begun a new journey as a Global Access Fellow with Goodlife Access, Goodlife Rwanda in collaboration with Roivant Social Ventures. I am thrilled to be spending my summer in Kigali, Rwanda serving to improve medication and healthcare access to those living in East Africa. Over the next 8 weeks, I will be helping to create sustainable and equitable resources for the community, while learning about the local health system and culture from the amazing team here. I would like to personally thank Ida-Alexandra de CORDIER, Josh Ruxin, David Zapol, and the rest of the Goodlife team for all of their support and for welcoming me into this role. I would also like to thank Amanda Waldhauser, Lindsay Androski, CFA, and those at RSV for making this possible! I look forward to the many opportunities to learn, grow, share, collaborate, and make a true impact, while continuing to carry forth this experience into my career and the communities I work with!

⛳⛵Finally had a chance to highlight the wonderful experience I had at Convergence Forum 2024 in Cape Cod. We had great discussions and debates with industry leaders on many of the forefront issues that the biotech and healthcare industries face today. Thank you again to Lindsay Androski, and Roivant Social Ventures for their generous sponsorship of my fellowship. Eager to carry forward these pivotal conversations. #CVForum2024 #Boston #biotech #venturecapital

Congratulations to Emilie Rodriguez from the The Bridge Directory on being recognized by the National Minority Quality Forum (NMQF) for winning their 2024 40 Under 40 Leaders in Health Award! As the nation's largest minority healthcare research, education, and advocacy organization, the NMQF recognizes professionals who have been leading the charge to better patient outcomes. From data to action, they are working to reduce patient risk and ensure access to optimal care, especially for those who are most vulnerable. “These young leaders are at the top of their fields representing the perspective of communities that have historically been invisible. Data shows us now that the work of these 40 under 40 leaders will be essential to meet the demand of the emerging, diverse health market.” said Dr. Gary Puckrein, President and Chief Executive Officer at the NMQF. “This year’s cohort of health leaders represent the best of the future of care for our nation,” stated Representative Robin Kelly, Chair of the Congressional Black Caucus Health Braintrust. “Their exceptional leadership and unwavering commitment to equity will undoubtedly inspire generations of providers to strive for excellence in their fields. I am confident that this class of health leaders will elevate the standard of care for patients and build a strong healthcare infrastructure for our country.” Emilie Rodriguez is Co-Founder and Executive Director of The Bridge Directory, an organization that seeks to heal the disparities in health and care from inside the system. Its mission is to connect families of color to supportive and culturally competent medical providers and professionals. Learn more about the Bridge Directory by visiting their website here: https://lnkd.in/gKxWv-mT

I had the incredible opportunity to attend the Convergence Conference for the first time last week, and what an enriching experience it was! Engaging discussions, valuable connections, and inspiring insights—looking forward to applying what I've learned. I want to extend my heartfelt gratitude to Lindsay Androski, CFA and Roivant Social Ventures for their generous sponsorship, which made my participation possible. Their support enabled me to delve into the latest advancements and trends shaping the biotech industry, fostering valuable connections along the way. #ConvergenceConference #Innovation #Networking #Gratitude #Fellowship #RoivantSocialVentures

Was just so thrilled and honored to be a Roivant Social Ventures Convergence Forum fellow this year at #CV2024. Extremely grateful to Lindsay Androski, CFA and Amanda Waldhauser for the opportunity, and to Shayne Gilbert and the rest of the organizers for such a galvanizing few days. Hope that it is the first time of many times for me to this incredible gathering of thinkers and doers -- can't wait to meet and see everyone again.